B

Bionano Genomics
D

BNGO

0.20000
USD
-0.00
(-1.04%)
قبل الجلسة
حجم التداول
200
الربح لكل سهم
-1
العائد الربحي
-
P/E
-0
حجم السوق
20,398,645
أصول ذات صلة
    E
    EDIT
    -0.01000
    (-0.75%)
    1.32000 USD
    N
    NCSM
    -0.340
    (-1.34%)
    24.990 USD
    N
    NTRA
    4.040
    (2.56%)
    161.910 USD
    O
    OOMA
    -0.020
    (-0.14%)
    14.380 USD
    P
    PSTG
    2.070
    (3.32%)
    64.400 USD
    R
    RARE
    0.770
    (1.77%)
    44.190 USD
    R
    RGNX
    0.22000
    (2.97%)
    7.63000 USD
    V
    VEEV
    4.360
    (1.98%)
    224.170 USD
    المزيد
الأخبار

العنوان: Bionano Genomics

القطاع: Healthcare
الصناعة: Medical Instruments & Supplies
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in Americas, EMEA and Asia Pacific; majority revenue being generated from Americas. They generate product revenue from sales of its OGM and Ionic Purification systems and consumables, which includes its instruments, and their VIA software.